EPISODE · Mar 9, 2021 · 14 MIN
BioLargo, Inc. Discusses Commercial PFAS Treatment Trials and Garratt-Callahan Partnership with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB:BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB:BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
BioLargo, Inc. Discusses Commercial PFAS Treatment Trials and Garratt-Callahan Partnership with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.